Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acetaminophen + pamabrom is an over-the-counter combination drug used primarily for the temporary relief of menstrual symptoms including cramps, backache, headache, bloating, and water-weight gain. Acetaminophen is a widely used analgesic and antipyretic that blocks pain impulse generation and inhibits prostaglandin synthesis in the central nervous system, thereby reducing pain and fever. Pamabrom is a mild xanthine diuretic that promotes increased urine output to decrease water retention and alleviates bloating. The combination targets the primary symptoms related to menstruation. This combo has FDA approval for these indications. Evidence for efficacy is established for acetaminophen, though robust comparative data versus NSAIDs are limited[1][3][4][5][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetaminophen + pamabrom.